Constellium SE (CSTM) concluded trading on Wednesday at a closing price of $10.11, with 4.5 million shares of worth about $45.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.93% during that period and on April 30, 2025 the price saw a gain of about 5.42%. Currently the company’s common shares owned by public are about 143.52M shares, out of which, 128.56M shares are available for trading.
Stock saw a price change of 14.50% in past 5 days and over the past one month there was a price change of 0.20%. Year-to-date (YTD), CSTM shares are showing a performance of -1.56% which decreased to -51.16% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $7.32 but also hit the highest price of $22.00 during that period. The average intraday trading volume for Constellium SE shares is 1.72 million. The stock is currently trading 15.24% above its 20-day simple moving average (SMA20), while that difference is down -1.04% for SMA50 and it goes to -19.99% lower than SMA200.
Constellium SE (NYSE: CSTM) currently have 143.52M outstanding shares and institutions hold larger chunk of about 86.19% of that.
The stock has a current market capitalization of $1.44B and its 3Y-monthly beta is at 1.58. PE ratio of stock for trailing 12 months is 32.50, while it has posted earnings per share of $0.31 in the same period. It has Quick Ratio of 0.45 while making debt-to-equity ratio of 2.88. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CSTM, volatility over the week remained 6.21% while standing at 7.52% over the month.
Stock’s fiscal year EPS is expected to rise by 179.61% while it is estimated to increase by 52.10% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Deutsche Bank on February 25, 2025 offering a Buy rating for the stock and assigned a target price of $15 to it. Coverage by Deutsche Bank stated Constellium SE (CSTM) stock as a Hold in their note to investors on October 24, 2024, suggesting a price target of $12 for the stock. On January 16, 2024, UBS Initiated their recommendations, while on May 08, 2023, JP Morgan Initiated their ratings for the stock with a price target of $24. Stock get a Neutral rating from JP Morgan on December 10, 2021.
